UBS starts Aurobindo Pharma stock with sell, sees low growth - Investing.com
| AUROPHARMA | 1,238 14.45 1.18% |
About 51% of Aurobindo Pharma's investor base is interested to short. The analysis of overall sentiment of trading Aurobindo Pharma Limited stock suggests that many investors are impartial at this time. The current market sentiment, together with Aurobindo Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Aurobindo Pharma stock news signals to limit their universe of possible portfolio assets.
Aurobindo |
UBS starts Aurobindo Pharma stock with sell, sees low growth Investing.com
Read at news.google.com
 |
Aurobindo Pharma Fundamental Analysis
We analyze Aurobindo Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aurobindo Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aurobindo Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Aurobindo Pharma is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Aurobindo Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aurobindo Pharma stock to make a market-neutral strategy. Peer analysis of Aurobindo Pharma could also be used in its relative valuation, which is a method of valuing Aurobindo Pharma by comparing valuation metrics with similar companies.
Peers
Aurobindo Pharma Related Equities
| ROHLTD | Royal Orchid | 1.84 | ||||
| EIHAHOTELS | EIH Associated | 1.73 | ||||
| KKCL | Kewal Kiran | 0.84 | ||||
| BFUTILITIE | BF Utilities | 0.11 | ||||
| IRISDOREME | Iris Clothings | 0.05 | ||||
| ASIANHOTNR | Asian Hotels | 0.77 | ||||
| ORIENTHOT | Oriental Hotels | 1.02 | ||||
| MIRCELECTR | MIRC Electronics | 2.50 |
Complementary Tools for Aurobindo Stock analysis
When running Aurobindo Pharma's price analysis, check to measure Aurobindo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurobindo Pharma is operating at the current time. Most of Aurobindo Pharma's value examination focuses on studying past and present price action to predict the probability of Aurobindo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurobindo Pharma's price. Additionally, you may evaluate how the addition of Aurobindo Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Correlations Find global opportunities by holding instruments from different markets |